To test this, IL-27R-/- mice infected with T. congolense were treated with depleting anti-mouse CD4 mAb, anti-mouse CD8 mAb, or rat IgG as control; and the course of infection, immune responses, and severity of liver damage were assessed. This evidence concerns the gene CD8A and infection.